Technology Offers



Screening System for Anti-Aging Substances

A new screening procedure for the identification of anti-aging substances has been developed at Heidelberg University. The procedure is based on a cell culture model and a fruit fly model to test for the organismic aging. In this way it is possible to quickly and effectively test the real potency of potential candidate substances.

 

 

Test for the Early Diagnosis of Cerebral Vasospasm

The invention concerns a novel procedure for the early detection of an increased risk of vasospasm by means of molecular indicators.

 

 

Fresh Wind Blowing for novel Radiopharmaceuticals

The technology concerns complexing agents for production of innovative radiopharmaceuticals that are based on metallic radionuclides. Radiopharmaceuticals are essential components in modern nuclear medicine. In the field of medical imaging radiodiagnostics are widely used in oncology and neurology especially as contrasting agents in positron emission tomography or during scintigraphy of the myocardium, spleen, skeleton, or the thyroid gland. Radiotherapeutics are primarily used in radioimmunology for tumor therapy and/or pain therapy. The chelate complexes of the present invention have been specifically designed for optimal complexing of 99mTc and 188/186Re (Tetrathiol derivates), or 67Cu and 64Cu (Bispidine derivates), or can be specifically adapted to these and additional radionuclides like 68Ga, 111In, 177Lu, 89Sr, 225Ac, 82Rb or 90Y (Bispidone derivates). Furthermore, the basic structure of the ligands can be conjugated with biomolecules (e.g. antibodies) for specific binding of tumors receptors or the like.